How does tretinoin act on leukaemia cells in acute promyelocytic leukaemia?

Tretinoin’s mechanism in acute promyelocytic leukaemia is not entirely known, but it induces degradation of PML/RARa, potentially releasing the differentiation block, and in combination with cytotoxic chemotherapy or arsenic trioxide inhibits proliferation and induces differentiation of promyelocytic blasts.